ClinicalTrials.govpublic full text
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
acute lymphoblastic leukemia, recurrent acute lymphoblastic leukemia, recurrent b acute lymphoblastic leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811895
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.